Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
84
SHC Quote, Financials, Valuation and Earnings
Last price:
$17.70
Seasonality move
:
18.76%
Day range:
$17.35 - $17.83
52-week range:
$9.53 - $17.78
Dividend yield:
0%
P/E ratio:
90.21x
P/S ratio:
4.32x
P/B ratio:
8.99x
Volume:
2.3M
Avg. volume:
2.9M
1-year change:
30.61%
Market cap:
$4.9B
Revenue:
$1.1B
EPS (TTM):
$0.19
Analysts' Opinion
-
Consensus RatingSotera Health Co. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $18.93, Sotera Health Co. has an estimated upside of 8.72% from its current price of $17.41.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.00 representing 100% downside risk from its current price of $17.41.
Fair Value
-
According to the consensus of 8 analysts, Sotera Health Co. has 8.72% upside to fair value with a price target of $18.93 per share.
SHC vs. S&P 500
-
Over the past 5 trading days, Sotera Health Co. has overperformed the S&P 500 by 2.21% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Sotera Health Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sotera Health Co. has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Sotera Health Co. reported revenues of $311.3M.
Earnings Growth
-
Sotera Health Co. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Sotera Health Co. reported earnings per share of $0.17.
Enterprise value:
6.9B
EV / Invested capital:
2.45x
Price / LTM sales:
4.32x
EV / EBIT:
17.15x
EV / Revenue:
6.02x
PEG ratio (5yr expected):
--
EV / Free cash flow:
60.32x
Price / Operating cash flow:
43.31x
Enterprise value / EBITDA:
12.60x
Gross Profit (TTM):
$600.9M
Return On Assets:
1.75%
Net Income Margin (TTM):
4.82%
Return On Equity:
11.79%
Return On Invested Capital:
1.98%
Operating Margin:
40.29%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $990.6M | $1.1B | $1.2B | $285.5M | $311.3M | |
| Gross Profit | $475.1M | $555.7M | $600.9M | $142.5M | $174.5M | |
| Operating Income | $316.4M | $360.5M | $403.7M | $91.1M | $125.4M | |
| EBITDA | $472.3M | $526.7M | $549.3M | $134.3M | $154.3M | |
| Diluted EPS | -$1.09 | $0.25 | $0.19 | $0.06 | $0.17 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $337.3M | $420.7M | $519.6M | $563.6M | $577.8M | |
| Total Assets | $2.7B | $2.8B | $3B | $3.1B | $3.2B | |
| Current Liabilities | $133.6M | $140M | $200.6M | $195.5M | $242.4M | |
| Total Liabilities | $2.2B | $2.2B | $2.7B | $2.7B | $2.6B | |
| Total Equity | $525.8M | $606.7M | $377.5M | $470.2M | $550.5M | |
| Total Debt | $1.8B | $1.8B | $2.3B | $2.4B | $2.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$184.6M | $249.5M | $267.9M | $95.6M | $69.6M | |
| Cash From Investing | -$221.8M | -$178M | -$150.3M | -$36.4M | -$33.3M | |
| Cash From Financing | $494.6M | -$15.8M | -$127M | -$804K | -$75.7M | |
| Free Cash Flow | -$406.5M | $71.5M | $114.8M | $59.2M | $33.4M | |
SHC
Sector
Market Cap
$4.9B
$28.1M
Price % of 52-Week High
97.92%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
0.31%
-1.49%
1-Year Price Total Return
30.61%
-17.13%
Beta (5-Year)
1.815
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$17.01
200-day SMA
Buy
Level
$13.86
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$17.00
Relative Strength Index (RSI14)
Buy
Level
68.35
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-3.3333
50-day SMA
Buy
Level
$16.54
MACD (12, 26)
Buy
Level
4.25
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3891)
Sell
CA Score
(Annual)
Level (-1.5258)
Buy
Beneish M-Score
(Annual)
Level (-2.7859)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (2.1789)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.
Stock Forecast FAQ
In the current month, SHC has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The SHC average analyst price target in the past 3 months is $18.93.
-
Where Will Sotera Health Co. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sotera Health Co. share price will rise to $18.93 per share over the next 12 months.
-
What Do Analysts Say About Sotera Health Co.?
Analysts are divided on their view about Sotera Health Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sotera Health Co. is a Sell and believe this share price will drop from its current level to $16.00.
-
What Is Sotera Health Co.'s Price Target?
The price target for Sotera Health Co. over the next 1-year time period is forecast to be $18.93 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is SHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sotera Health Co. is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SHC?
You can purchase shares of Sotera Health Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sotera Health Co. shares.
-
What Is The Sotera Health Co. Share Price Today?
Sotera Health Co. was last trading at $17.70 per share. This represents the most recent stock quote for Sotera Health Co.. Yesterday, Sotera Health Co. closed at $17.41 per share.
-
How To Buy Sotera Health Co. Stock Online?
In order to purchase Sotera Health Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHC
Sector
P/E ratio
90.21x
23.89x
PEG ratio
--
-0.01x
P/B ratio
8.99x
1.81x
Price / LTM sales
4.32x
1.59x
Growth Metrics
SHC
Sector
Revenue growth
9.05%
4.62%
Earnings growth
183.7%
11.06%
Revenue (5-year growth)
7.17%
6.5%
Earnings forecast
$0.22
-$0.21
Profitability
SHC
Sector
Profitability FY 2024
$540.3M
$3.6M
Return on invested capital
1.98%
-31.84%
Return on assets
1.75%
-27.96%
Return on equity
11.79%
-37.63%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
3
Balance Sheet
SHC
Sector
Total cash
$301M
$26.4M
Short term investments
--
$25.7M
Total assets
$3.2B
$76.9M
Long term debt
$2.3B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
